Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2020

Jan 21, 2020

31802_dirs_2020-01-21_faecb9d6-e4b6-4548-a1f2-664753eaa29d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-01-17

Reporting Person: Seith Douglas J (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-17 Common Stock M 38000 $6.73 Acquired 147772 Direct
2020-01-17 Common Stock F 15090 $38.00 Disposed 129182 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-17 Stock Option (Right to buy) $6.73 M 38000 Disposed 2022-12-27 Common Stock (38000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3500 Indirect

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

F4: These options were granted on December 27, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.